Scientists in Australia have completed an extensive examination of medical literature concerning electronic cigarettes, including animal studies and case reports. Their findings present convincing evidence that vaping products carry a risk of causing cancer in users.

Assessing the Cancer Hazard of E-Cigarettes

Focus Shift from Gateway Effect to Carcinogenicity

For the past decade and a half, e-cigarettes have gained popularity as an alternative to traditional tobacco products. While many experts agree vaping is substantially safer than smoking, ongoing debate surrounds its potential long-term health consequences.

The researchers noted that most previous studies focused on whether vaping acts as a gateway to traditional smoking, especially among younger demographics. They argue that significantly less attention has been dedicated to whether long-term vaping itself can induce cancer.

Qualitative Risk Assessment Conducted

To address this gap, the research team performed a “qualitative risk assessment.” This involved analyzing existing laboratory research, animal models, and documented case reports where cancer was suspected following vaping use.

The analysis concluded there was sufficient data to establish a link between vaping and cancer development. Studies have shown that compounds or byproducts from e-cigarettes, such as certain metals and flavoring agents, can damage cellular DNA.

Key Findings and Expert Commentary

Oral and Lung Cancer Risk Identified

Biomarker studies further indicated that vaping can cause inflammation and damage to respiratory and oral tissues, conditions that may elevate cancer risk. Study author Bernard Stewart, a cancer researcher at the University of New South Wales, stated, “To our knowledge, this review is the most definitive determination that those who vape are at increased risk of cancer compared to those who don’t.”

The authors explicitly concluded that “Nicotine-based e-cigarettes are likely to be carcinogenic to humans who use them causing an indeterminate burden of oral cancer and lung cancer,” according to their published paper.

Quantifying the Risk Remains Difficult

The researchers cautioned that the current body of evidence does not allow for the quantification of the precise cancer risk posed by vaping products. They suggest that determining this level will require long-term studies, similar to those that established smoking's carcinogenic danger.

External Skepticism and Context

Not all external experts were fully convinced by the review's conclusions. Lion Shahab, co-director of the Tobacco and Alcohol Research Group at University College London, urged against sensationalizing the evidence, noting that the review “does not offer a ‘smoking gun’ that e-cigarettes cause oral or lung cancer.”

Despite these findings, some health bodies still promote vaping as a tool for smokers to quit. They maintain that switching from smoking to vaping reduces cancer risk because vaping is significantly less harmful than smoking. While avoiding nicotine entirely is ideal, experts suggest vaping remains the safer long-term choice over continued smoking.